China
VectorBuilder and Sartorius Announce Strategic Partnership to Advance Gene Delivery and mRNA Bioprocess Solutions
VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in life science research and the biopha...
November 27, 2024 | News
Duality Biologics and Adcendo Expand Collaboration to Strengthen ADC Cancer Therapy Pipeline
Duality Biologics ("Duality"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate therap...
November 26, 2024 | News
ArkBio Completes Phase 1 Enrollment for AK0610, Pioneering RSV Prevention for Vulnerable Infants
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK061...
November 25, 2024 | News
Lepu Biopharma and DP Technology Achieve Milestone in ADC Drug Development Through AI-Powered Collaboration
This partnership has effectively integrated DP's ADC Linker-Payload design platform with Lepu's ADC technology development platform, capitalizing on t...
November 22, 2024 | News
Ractigen Therapeutics Receives FDA Orphan Drug Designation for RAG-21, a Novel siRNA Therapy for FUS-ALS
Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, announced that the U.S. Food and Drug Administ...
November 20, 2024 | News
Huahui Health's Libevitug Receives FDA Breakthrough Therapy Designation for Chronic Hepatitis Delta
Huahui Health, a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis, hepatology, an...
November 19, 2024 | News
VelaVigo and Avenzo Therapeutics Join Forces to Develop Nectin4/TROP2 Bispecific ADC for Global Markets
VelaVigo Cayman Limited (VelaVigo), a biotech company focusing on discovery and development of multi-specific antibodies and antibody-drug conjugates...
November 19, 2024 | News
Biosion Secures $40M Upfront in Licensing Deal with Aclaris Therapeutics, with Milestones Exceeding $900M
Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materi...
November 19, 2024 | News
Ascentage Pharma’s Lisaftoclax NDA Accepted for Priority Review in China: A Potential First for Bcl-2 Inhibitors
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unm...
November 18, 2024 | News
Terumo BCT Partners with Terumo Medical Products Hangzhou to Launch Local Manufacturing in China, Boosting Medical Device Production for Domestic Market
Terumo BCT announced a strategic partnership with Terumo Medical Products (Hangzhou) Co., Ltd., investing in its production facility located in the Qiant...
November 15, 2024 | News
Terumo BCT Partners with Terumo Medical Products Hangzhou to Launch Local Manufacturing in China, Boosting Medical Device Production for Domestic Market
Terumo BCT announced a strategic partnership with Terumo Medical Products (Hangzhou) Co., Ltd., investing in its production facility located in the Qiant...
November 15, 2024 | News
Mabwell's Nectin-4 Targeting ADC Secures IND Approval for Clinical Trials in Perioperative Urothelial Carcinoma and Advanced Solid Tumors
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its novel Nectin-4 targeting ADC (R&D code: 9MW...
November 15, 2024 | News
Novotech and Biostar Announce Long-Term Partnership to Accelerate Oncology Clinical Development
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advan...
November 13, 2024 | News
Ascletis Completes Enrollment for Phase III Trial of ASC40 in Acne
Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 Ascletis Pharma Inc. ann...
November 13, 2024 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
